Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)

NCT01473264 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome in Premature Infant
Bronchopulmonary Dysplasia

Interventions

DRUG: recombinant human CC10 (rhCC10)
DRUG: recombinant human CC10 (rhCC10)
DRUG: placebo

Sponsor

Clarassance, Inc.

Collaborators

[object Object]